References - Therapeutic Strategies in Cancer Biology and Pathology - page 218

Ismail, T.M., Zhang, S., Fernig, D.G., Gross, S., Martin-Fernandez, M.L., See, V., et al., 2010.
Self-association of calcium-binding protein S100A4 and metastasis. J. Biol. Chem. 285,
914-922.
Itani, S., Kunisada, T., Morimoto, Y., Yoshida, A., Sasaki, T., Ito, S., et al., 2012. MicroRNA-21
correlates with tumorigenesis in malignant peripheral nerve sheath tumor (MPNST) via
programmed cell death protein 4 (PDCD4). J. Cancer Res. Clin. Oncol. 138, 1501-1509.
Jacoby, J.J., Erez, B., Korshunova, M.V., Williams, R.R., Furutani, K., Takahashi, O., et al.,
2010. Treatment with HIF-1 alpha antagonist PX-478 inhibits progression and spread of
orthotopic human small cell lung cancer and lung adenocarcinoma in mice. J. Thoracic.
Oncol. 5, 940-949.
Jagani, Z., Wiederschain, D., Loo, A., He, D., Mosher, R., Fordjour, P., et al., 2010. The
Polycomb group protein Bmi-1 is essential for the growth of multiple myeloma cells.
Cancer Res. 70, 5528-5538.
Janoueix-Lerosey, I., Lequin, D., Brugieres, L., Ribeiro, A., de Pontual, L., Combaret, V.,
et al., 2008. Somatic and germline activating mutations of the ALK kinase receptor in
neuroblastoma. Nature 455, 967-970.
Jara-Lazaro, A.R., Akhilesh, M., Thike, A.A., Lui, P.C.W., Tse, G.M.K., Tan, P.H., 2010.
Down-regulation of ING4 is associated with initiation and progression of lung cancer.
Histopathology 57, 220-232.
Jazirehi, A.R., Huerta-Yepez, S., Cheng, G., Bonavida, B., 2005. Rituximab (chimeric anti-
CD20 monoclonal antibody) inhibits the constitutive nuclear factor-kappa B signaling
pathway in non-Hodgkin's lymphoma B-cell lines: role in sensitization to chemothera-
peutic drug-induced apoptosis. Cancer Res. 65, 264-276.
Jensen, J.D., Knoop, A., Laenkholm, A.V., Grauslund, M., Jensen, M.B., Santoni-Rugiu, E.,
et al., 2012. PIK3CA mutations, PTEN, and pHER2 expression and impact on outcome
in HER2-positive early-stage breast cancer patients treated with adjuvant chemotherapy
and trastuzumab. Ann. Oncol. 23, 2034-2042.
Jeon, H.M., Jin, X., Lee, J.S., Oh, S.Y., Sohn, Y.W., Park, H.J., et al. 2008. Inhibitor of dif-
ferentiation 4 drives brain tumor-initiating cell genesis through cyclin E and notch signal-
ing. Genes Develop 22, 2028-2033.
Jeon, H.M., Sohn, Y.W., Oh, S.Y., Kim, S.H., Beck, S., Kim, S., 2011. ID4 imparts chemore-
sistance and cancer stemness to glioma cells by derepressing miR-9*-mediated suppres-
sion of SOX2. Cancer Res. 71, 3410-3421.
Jhanwar-Uniyal, M., 2003. BRCA1 in cancer, cell cycle and genomic stability. Front. Biosci.
8, S1107-S1117.
Ji, H., Ramsey, M.R., Hayes, D.N., Fan, C., McNamara, K., Kozlowski, P., et al., 2007. LKB1
modulates lung cancer differentiation and metastasis. Nature 448, 807-810.
Jia, C.Y., Li, H.H., Zhu, X.C., Dong, Y.W., Fu, D., Zhao, Q.L., et al., 2011. MiR-223 sup-
presses cell proliferation by targeting IGF-1R. PLoS ONE 6, e27008.
Jiang, Z., Wang, Z., Xu, Y., Wang, B., Huang, W., Cai, S., 2010. Analysis of RGS2 expression
and prognostic significance in stage II and III colorectal cancer. Biosci. Rep. 30, 383-390.
Jin, Y., Lu, Z., Ding, K., Li, J., Du, X., Chen, C., et al., 2010. Antineoplastic mechanisms of
Niclosamide in acute myelogenous leukemia stem cells: inactivation of the NF-kappa B
pathway and generation of reactive oxygen species. Cancer Res. 70, 2516-2527.
Jones, J.L., Royall, J.E., Walker, R.A., 1996. E-cadherin relates to EGFR expression and
lymph node metastasis in primary breast carcinoma. Br. J. Cancer 74, 1237-1241.
Jones, L., Hamilton, A.J., Voinnet, O., Thomas, C.L., Maule, A.J., Baulcombe, D.C., 1999.
RNA-DNA interactions and DNA methylation in posttranscriptional gene silencing.
Plant Cell 11, 2291-2301.